BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
-0.98%
-7.00p
705.00p
17:17 23/06/17
705.00p
17:17 23/06/17
DAILY VARIATION
-0.98%
-7.00p
VOLUME
353,181
REAL TIME BATS
702.50p
17:36 23/06/17
-1.33%
-9.50p
DATA
52 Week High
n/a
52 Week Low
n/a
Shares Issued
385.74m
Market Cap
£2,719.47m
RiskGrade
n/a
Beta
n/a
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 10.1% 23.3%
ROCE 24.7%
Latest F'cast
P/E 30.5 22.6
PEG 5.6 0.9
Pr/Revenue 4.8 4.6
Pr/Book 2.8
Latest F'cast
Revenue 27.5% 0.2%
PBT -45.0% n/a
EPS 5.5% -5.5%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%
2016-03-31 447.50 57.50 21.90p 28.4 0.7 39% n/a 0.0%
2017-03-31 570.50 31.60 23.10p 25.4 4.6 5% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2018-03-31 596.42 138.99 29.46p 22.6 0.8 28% 0.00p 0.0%
2019-03-31 635.70 165.07 33.97p 19.5 1.3 15% 0.00p 0.0%

Regulatory News

slide to see more
Holding(s) in Company 23-Jun-17 15:12
Holding(s) in Company 21-Jun-17 10:03
Price Monitoring Extension 16-Jun-17 16:36

Newspaper Links

No results found